Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RIGL | ZTS | TAK | UTHR | NBIX |
| Company | Rigel Pharmaceuticals | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.1200 | 151.63 | 13.16 | 234.67 | 133.23 |
| High | 1.1200 | 153.67 | 13.23 | 240.74 | 134.20 |
| Low | 1.0500 | 151.17 | 13.12 | 234.31 | 131.00 |
| Last | 1.0500 | 153.11 | 13.16 | 236.93 | 132.54 |
| Change | -0.0600 | +1.60 | +0.01 | +1.62 | -0.69 |
| % Change | -5.41% | +1.06% | +0.08% | +0.69% | -0.52% |
| Volume | 1,236,200 | 4,772,847 | 1,286,645 | 476,300 | 586,500 |
| 20-Day Average Volume | 1,486,230 | 3,894,475 | 1,855,305 | 519,620 | 859,780 |
| Previous Close | 1.1100 | 151.51 | 13.15 | 235.31 | 133.23 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2945 | 162.57 | 13.69 | 235.81 | 137.66 |
| 20-Day Raw Stochastic | 0.00% | 17.91% | 3.52% | 52.45% | 8.87% |
| 20-Day Relative Strength | 32.67% | 31.45% | 32.77% | 53.29% | 43.06% |
| Weighted Alpha | -20.52 | -19.08 | -22.35 | +4.86 | +28.59 |
| Today's Opinion | 24% Sell | 88% Sell | 100% Sell | 88% Buy | 40% Buy |
| Previous Opinion | 8% Sell | 88% Sell | 100% Sell | 72% Buy | 56% Buy |
| Last Month's Opinion | 72% Buy | 8% Sell | 48% Sell | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.63% since 04/11/24 | -5.91% since 04/11/24 | -3.09% since 04/11/24 | -0.13% since 04/11/24 | -2.49% since 04/11/24 |
| Low | 1.0500 on 04/18/24 | 148.48 on 04/12/24 | 13.11 on 04/17/24 | 230.39 on 04/16/24 | 131.00 on 04/18/24 |
| High | 1.2400 on 04/12/24 | 155.98 on 04/12/24 | 13.56 on 04/12/24 | 240.74 on 04/18/24 | 137.78 on 04/12/24 |
| 1-Month | |||||
| %Chg | -21.64% since 03/18/24 | -10.30% since 03/18/24 | -9.62% since 03/18/24 | +1.27% since 03/18/24 | -4.95% since 03/18/24 |
| Low | 1.0500 on 04/18/24 | 148.48 on 04/12/24 | 13.11 on 04/17/24 | 221.53 on 04/01/24 | 131.00 on 04/18/24 |
| High | 1.5050 on 03/28/24 | 174.33 on 03/21/24 | 14.55 on 03/20/24 | 250.89 on 03/26/24 | 148.37 on 03/21/24 |
| 3-Month | |||||
| %Chg | -21.64% since 01/18/24 | -19.63% since 01/18/24 | -11.50% since 01/18/24 | +8.13% since 01/18/24 | -3.08% since 01/18/24 |
| Low | 1.0500 on 04/18/24 | 148.48 on 04/12/24 | 13.11 on 04/17/24 | 208.62 on 02/08/24 | 128.00 on 02/07/24 |
| High | 1.7300 on 03/06/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 250.89 on 03/26/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | +10.61% since 10/18/23 | -9.69% since 10/18/23 | -10.05% since 10/18/23 | +2.87% since 10/18/23 | +18.11% since 10/18/23 |
| Low | 0.7120 on 10/25/23 | 148.48 on 04/12/24 | 13.11 on 04/17/24 | 208.62 on 02/08/24 | 103.63 on 11/10/23 |
| High | 1.7300 on 03/06/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 258.31 on 12/14/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 194,700 | 69,491,128 | 41,617,356 | 11,073,451 | 13,257,318 |
| Shares Outstanding, K | 175,405 | 457,359 | 3,164,818 | 47,059 | 99,507 |
| Annual Sales | 116,880,000 | 8,544,000,000 | 29,803,340,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -25,090,000 | 2,344,000,000 | 2,345,930,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 35,790,000 | 2,213,000,000 | 7,556,070,000 | 614,700,000 | 515,200,000 |
| Last Quarter Net Income | 740,000 | 525,000,000 | 718,900,000 | 217,100,000 | 147,700,000 |
| 60-Month Beta | 0.95 | 0.85 | 0.53 | 0.52 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 03/05/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 4.36 on 02/21/24 | 1.44 on 02/07/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.76 | 6.78 | 11.68 | 54.95 |